438 related items for PubMed ID: 9517598
1. Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.
Pauwels RA, Yernault JC, Demedts MG, Geusens P.
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):827-32. PubMed ID: 9517598
[Abstract] [Full Text] [Related]
2. A randomized, double-blind comparison of beclomethasone dipropionate extrafine aerosol and fluticasone propionate.
Fairfax A, Hall I, Spelman R.
Ann Allergy Asthma Immunol; 2001 May; 86(5):575-82. PubMed ID: 11379810
[Abstract] [Full Text] [Related]
3. The comparison of the effects of fluticasone propionate and budesonide on clinical indices and on bone mineral density in the asthmatic patients: a one year treatment study.
Harmanci E, Ak I, Ozdemir N, Vardareli E, Elbek O, Uçgun I.
Allergol Immunopathol (Madr); 1999 May; 27(6):298-303. PubMed ID: 10611554
[Abstract] [Full Text] [Related]
4. Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.
Woolcock A, Lundback B, Ringdal N, Jacques LA.
Am J Respir Crit Care Med; 1996 May; 153(5):1481-8. PubMed ID: 8630590
[Abstract] [Full Text] [Related]
5. Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate.
Bootsma GP, Dekhuijzen PN, Festen J, Mulder PG, Swinkels LM, van Herwaarden CL.
Am J Respir Crit Care Med; 1996 Mar; 153(3):924-30. PubMed ID: 8630574
[Abstract] [Full Text] [Related]
6. Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less.
Barnes NC, Hallett C, Harris TA.
Respir Med; 1998 Jan; 92(1):95-104. PubMed ID: 9519232
[Abstract] [Full Text] [Related]
7. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216
[Abstract] [Full Text] [Related]
8. A comparison of fluticasone propionate, 1 mg daily, with beclomethasone dipropionate, 2 mg daily, in the treatment of severe asthma. International Study Group.
Barnes NC, Marone G, Di Maria GU, Visser S, Utama I, Payne SL.
Eur Respir J; 1993 Jun; 6(6):877-85. PubMed ID: 8339809
[Abstract] [Full Text] [Related]
9. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
Aubier M, Pieters WR, Schlösser NJ, Steinmetz KO.
Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
[Abstract] [Full Text] [Related]
10. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
11. The CONCEPT trial: a 1-year, multicenter, randomized,double-blind, double-dummy comparison of a stable dosing regimen of salmeterol/fluticasone propionate with an adjustable maintenance dosing regimen of formoterol/budesonide in adults with persistent asthma.
FitzGerald JM, Boulet LP, Follows RM.
Clin Ther; 2005 Apr; 27(4):393-406. PubMed ID: 15922813
[Abstract] [Full Text] [Related]
12. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
Galant SP, van Bavel J, Finn A, Gross G, Pleskow W, Brown A, Hamedani AG, Harding SM.
Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
[Abstract] [Full Text] [Related]
13. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
Lee DK, Jackson CM, Currie GP, Cockburn WJ, Lipworth BJ.
Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
[Abstract] [Full Text] [Related]
14. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
Bousquet J, Boulet LP, Peters MJ, Magnussen H, Quiralte J, Martinez-Aguilar NE, Carlsheimer A.
Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
[Abstract] [Full Text] [Related]
15. Equivalent efficacy and safety of a new HFA-134a formulation of BDP compared with the conventional CFC in adult asthmatics.
Anderson PB, Langley SJ, Mooney P, Jones J, Addlestone R, Rossetti A, Cantini L.
J Investig Allergol Clin Immunol; 2002 Dec; 12(2):107-13. PubMed ID: 12371526
[Abstract] [Full Text] [Related]
16. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
Tatsis G, Kotsifas K, Filaditaki V, Makrantoni G, Boulia S.
J Int Med Res; 2007 Dec; 35(3):361-73. PubMed ID: 17593865
[Abstract] [Full Text] [Related]
17. [A fixed combination of fluticasone and salmeterol permits better control of asthma than a beclomethasone dipropionate and montelukast combination].
Grosclaude M, Cerruti JL, Delannay B, Hérent M, Spilthooren F, Desfougères JL.
Eur Ann Allergy Clin Immunol; 2003 Nov; 35(9):356-62. PubMed ID: 14716965
[Abstract] [Full Text] [Related]
18. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
Popov TA, Petrova D, Kralimarkova TZ, Ivanov Y, Popova T, Peneva M, Odzhakova T, Ilieva Y, Yakovliev P, Lazarova T, Georgiev O, Hodzhev V, Hodzheva E, Staevska MT, Dimitrov VD.
Pulm Pharmacol Ther; 2013 Dec; 26(6):624-9. PubMed ID: 23769863
[Abstract] [Full Text] [Related]
19. Fluticasone alone or in combination with salmeterol vs triamcinolone in asthma.
Baraniuk J, Murray JJ, Nathan RA, Berger WE, Johnson M, Edwards LD, Srebro S, Rickard KA.
Chest; 1999 Sep; 116(3):625-32. PubMed ID: 10492263
[Abstract] [Full Text] [Related]
20. Evaluation of different inhaled combination therapies (EDICT): a randomised, double-blind comparison of Seretide (50/250 microg bd Diskus vs. formoterol (12 microg bd) and budesonide (800 microg bd) given concurrently (both via Turbuhaler) in patients with moderate-to-severe asthma.
Ringdal N, Chuchalin A, Chovan L, Tudoric N, Maggi E, Whitehead PJ, EDICT Investigators.
Respir Med; 2002 Nov; 96(11):851-61. PubMed ID: 12418582
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
